Biochemical Basis of Vosevi, a New Treatment for Hepatitis CPublished as part of the Biochemistry series "Biochemistry to Bedside"

Biochemistry. 2018 Feb 6;57(5):479-480. doi: 10.1021/acs.biochem.7b01157. Epub 2017 Nov 29.

Abstract

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoisobutyric Acids
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Carbamates / pharmacology
  • Carbamates / therapeutic use*
  • Cyclopropanes
  • Drug Combinations
  • Hepacivirus / drug effects*
  • Hepacivirus / metabolism
  • Hepatitis / drug therapy*
  • Hepatitis / virology
  • Heterocyclic Compounds, 4 or More Rings / pharmacology
  • Heterocyclic Compounds, 4 or More Rings / therapeutic use*
  • Humans
  • Lactams, Macrocyclic
  • Leucine / analogs & derivatives
  • Macrocyclic Compounds / pharmacology
  • Macrocyclic Compounds / therapeutic use*
  • Proline / analogs & derivatives
  • Quinoxalines
  • Serine Proteases / metabolism
  • Sofosbuvir / pharmacology
  • Sofosbuvir / therapeutic use*
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use*
  • Viral Nonstructural Proteins / antagonists & inhibitors
  • Viral Nonstructural Proteins / metabolism

Substances

  • Aminoisobutyric Acids
  • Antiviral Agents
  • Carbamates
  • Cyclopropanes
  • Drug Combinations
  • Heterocyclic Compounds, 4 or More Rings
  • Lactams, Macrocyclic
  • Macrocyclic Compounds
  • Quinoxalines
  • Sulfonamides
  • Viral Nonstructural Proteins
  • voxilaprevir
  • Proline
  • NS-5 protein, hepatitis C virus
  • NS3-4A serine protease, Hepatitis C virus
  • Serine Proteases
  • Leucine
  • velpatasvir
  • Sofosbuvir